Publicacións nas que colabora con Salvador Martín Algarra (16)

2016

  1. GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases

    Annals of Oncology, Vol. 27, pp. vi383

2007

  1. Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

    Clinical and Translational Oncology, Vol. 9, Núm. 2, pp. 119-120

2006

  1. Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement

    Clinical and Translational Oncology, Vol. 8, Núm. 5, pp. 369-371

2004

  1. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients

    Bone Marrow Transplantation, Vol. 33, Núm. 5, pp. 499-502

  2. Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 27, Núm. 3, pp. 299-303

  3. Preliminary experience with intensity modulated radiation therapy for abdominopelvic tumor sites: A comparison with 3D radiotherapy plans

    Clinical and Translational Oncology, Vol. 6, Núm. 7, pp. 415-423

  4. Preliminary experience with intensity modulated radiation therapy for abdominopelvic tumor sites: a comparison with 3D radiotherapy plans

    Revista de oncología: Publicación oficial de la Federación de Sociedades Españolas de Oncología y del Instituto Nacional de Cancerología de México, Vol. 6, Núm. 7, pp. 415-423

2003

  1. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer

    Oncology, Vol. 64, Núm. 1, pp. 28-35

  2. Radioterapia en cáncer de recto localmente avanzado: situación actual y desarrollo terapéutico

    Revista de medicina, Vol. 47, Núm. 1, pp. 56-63

  3. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 26, Núm. 1, pp. 30-36

2002

  1. Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 4, pp. 347-353

  2. Second-line chemotherapy with irinotecan and vinorelbine in stage IIIb and IV non-small-cell lung cancer: A phase II study

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, Núm. 5, pp. 480-484

1998

  1. Descenso de estadificacion despues de carboplatino y 5-fluorouracilo simultaneo durante radioterapia preoperatoria en carcinoma primario de recto

    Revisiones en Cancer, Vol. 12, Núm. 3, pp. 125-129

1996

  1. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: Benefit for selected patients

    Bone Marrow Transplantation, Vol. 18, Núm. 1, pp. 143-149

1992

  1. Tratamiento intensivo de sarcomas oseos de histologia miscelanea: histiocitoma fibroso maligno y condrosarcoma

    Oncologia, Vol. 15, Núm. 8, pp. 351-358

1990

  1. Intensive chemotherapy with 1-3 drugs and support with autologous myelopoietic cells extracted from the peripheral blood: the preliminary results

    Revista de medicina de la Universidad de Navarra, Vol. 34, Núm. 1, pp. 51-54